Trupanion, Inc. (NASDAQ:TRUP) Receives Consensus Rating of “Moderate Buy” from Analysts

Trupanion, Inc. (NASDAQ:TRUP) has earned a consensus rating of “Moderate Buy” from the six research firms that are covering the firm, MarketBeat.com reports. One analyst has rated the stock with a sell rating, two have given a hold rating, two have issued a buy rating and one has assigned a strong buy rating to the company. The average 12 month target price among brokerages that have issued a report on the stock in the last year is $41.60.

TRUP has been the subject of a number of recent analyst reports. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Trupanion in a research report on Monday, June 1st. Atlantic Securities set a $42.00 price objective on shares of Trupanion in a research note on Wednesday, July 15th. Zacks Research raised shares of Trupanion from a “hold” rating to a “strong-buy” rating in a report on Friday, July 24th. Bank of America decreased their price objective on shares of Trupanion from $63.00 to $59.00 and set a “buy” rating for the company in a report on Tuesday, April 14th. Finally, Stifel Nicolaus set a $28.00 target price on shares of Trupanion in a research note on Friday, June 26th.

Trupanion Price Performance

Shares of NASDAQ:TRUP opened at $26.99 on Monday. The stock has a market capitalization of $1.18 billion, a P/E ratio of 50.93, a P/E/G ratio of 1.98 and a beta of 1.39. The business has a 50-day moving average of $24.72 and a two-hundred day moving average of $26.13. Trupanion has a fifty-two week low of $21.16 and a fifty-two week high of $57.00. The company has a debt-to-equity ratio of 0.24, a current ratio of 1.77 and a quick ratio of 1.77.

Trupanion (NASDAQ:TRUP) last issued its quarterly earnings data on Wednesday, August 5th. The financial services provider reported $0.16 EPS for the quarter, beating analysts’ consensus estimates of $0.11 by $0.05. Trupanion had a return on equity of 5.96% and a net margin of 1.53%.The business had revenue of $392.93 million for the quarter, compared to analyst estimates of $389.72 million. During the same quarter in the prior year, the firm posted $0.22 EPS. The firm’s revenue for the quarter was up 11.1% on a year-over-year basis. On average, equities research analysts predict that Trupanion will post 0.58 EPS for the current fiscal year.

Insider Activity

In other news, CFO Fawwad Qureshi sold 6,177 shares of the firm’s stock in a transaction dated Wednesday, May 27th. The stock was sold at an average price of $22.18, for a total value of $137,005.86. Following the sale, the chief financial officer directly owned 2,081 shares of the company’s stock, valued at approximately $46,156.58. This trade represents a 74.80% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, EVP Steve Weinrauch sold 6,674 shares of the business’s stock in a transaction dated Friday, June 5th. The stock was sold at an average price of $22.00, for a total value of $146,828.00. Following the transaction, the executive vice president directly owned 78,062 shares of the company’s stock, valued at $1,717,364. This represents a 7.88% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders have sold 17,807 shares of company stock valued at $394,452. 5.58% of the stock is owned by insiders.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of TRUP. BlackRock Inc. acquired a new position in Trupanion in the 2nd quarter valued at approximately $134,774,000. Millennium Management LLC grew its holdings in shares of Trupanion by 185.8% during the 3rd quarter. Millennium Management LLC now owns 619,003 shares of the financial services provider’s stock worth $26,790,000 after purchasing an additional 402,421 shares in the last quarter. Renaissancere Holdings Ltd. acquired a new stake in shares of Trupanion during the 2nd quarter worth approximately $6,514,510,000. Goldman Sachs Group Inc. increased its position in shares of Trupanion by 116.4% during the fourth quarter. Goldman Sachs Group Inc. now owns 477,014 shares of the financial services provider’s stock valued at $17,826,000 after purchasing an additional 256,559 shares during the period. Finally, Two Sigma Investments LP increased its position in shares of Trupanion by 3,201.0% during the third quarter. Two Sigma Investments LP now owns 224,433 shares of the financial services provider’s stock valued at $9,713,000 after purchasing an additional 217,634 shares during the period.

About Trupanion

Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.

Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.